These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35373259)

  • 1. Role of Aspirin in Gastric Cancer Prevention.
    Umar A; Loomans-Kropp HA
    Cancer Prev Res (Phila); 2022 Apr; 15(4):213-215. PubMed ID: 35373259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin induced apoptosis in gastric cancer cells.
    Wong BC; Zhu GH; Lam SK
    Biomed Pharmacother; 1999 Aug; 53(7):315-8. PubMed ID: 10472431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
    Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
    Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Kwiecień S; Pajdo R; Ptak A; Pawlik M; Hahn E
    Dig Liver Dis; 2000 Oct; 32(7):583-94. PubMed ID: 11142556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medicinal chemistry implications of the anticancer effects of aspirin and other NSAIDs.
    Gardiner PS; Gilmer JF
    Mini Rev Med Chem; 2003 Aug; 3(5):461-70. PubMed ID: 12769697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of non-steroidal anti-inflammatory drugs and cancer.
    Baron JA
    Prog Exp Tumor Res; 2003; 37():1-24. PubMed ID: 12795046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ; Qiao YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb; 23(1):78-82. PubMed ID: 12905826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
    Chan AT; Ogino S; Fuchs CS
    N Engl J Med; 2007 May; 356(21):2131-42. PubMed ID: 17522398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NSAIDs and gastrointestinal cancer prevention.
    Jolly K; Cheng KK; Langman MJ
    Drugs; 2002; 62(6):945-56. PubMed ID: 11929340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study.
    Kwon S; Ma W; Drew DA; Klempner SJ; Leonardo BM; Flynn JJ; Cao Y; Giovannucci EL; Bao Y; Fuchs CS; Song M; Chan AT
    Cancer Prev Res (Phila); 2022 Apr; 15(4):265-272. PubMed ID: 34980677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevention of colorectal cancer by aspirin use.
    Giovannucci E
    Biomed Pharmacother; 1999 Aug; 53(7):303-8. PubMed ID: 10472428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and the prevention of colorectal cancer.
    Berman KS
    N Engl J Med; 2003 Jun; 348(24):2466-7; author reply 2466-7. PubMed ID: 12803217
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
    Cao Y; Nishihara R; Wu K; Wang M; Ogino S; Willett WC; Spiegelman D; Fuchs CS; Giovannucci EL; Chan AT
    JAMA Oncol; 2016 Jun; 2(6):762-9. PubMed ID: 26940135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review.
    Belayneh YM; Amare GG; Meharie BG
    J Oncol Pharm Pract; 2021 Jun; 27(4):954-961. PubMed ID: 33427041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).
    Harris RE; Beebe-Donk J; Doss H; Burr Doss D
    Oncol Rep; 2005 Apr; 13(4):559-83. PubMed ID: 15756426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and colon cancer--targeting prevention?
    Markowitz SD
    N Engl J Med; 2007 May; 356(21):2195-8. PubMed ID: 17522404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.